Monday, 4 May 2026
  
Login

Australia's most trusted
source of pharma news

Monday, 4 May 2026
Ascott 1
Ascott 1
Why pharma new hires are quitting

Australian pharma companies are driving new hires to quit because of this single, critical failure during onboarding. A recruitment expert reveals what it is and how it's costing  hundreds of thousands of dollars.

Blast from the past heads to PBAC
A treatment deferred four years ago is back on the agenda, along with a cancer drug that was marked 'ceased' at the start of April
TODAY
siRNA specialist enters Aust market
TGA approves first-in-class siRNA therapeutic, a new brand of Eisai's kinase inhibitor, plus a long list of generics of PBS listed drugs
TODAY Approvals Action
Medscape
Medscape
Who's won an MA Board seat?
After 10 Country Leaders put up their hand to join the Board of industry peak body, these four made the cut
1 May
Aussie pharma on the nose
Industry's approval rating among patients fell nine per cent, one of the worst global results but not everyone's in the bad books
1 May
High-flyers on the move in pharma
Top-level appointments announced including one executive who has switched between the same two companies over eight years
30 April
Which CAR T saved Sam Neill?
An experimental therapy has eliminated Neill's cancer, with the actor describing himself as 'patient zero' for the new treatment
30 April
HPG
HPG
Latest Jobs
Drought strikes May PBS listings
PBS listings have dried up with only three additions to the scheme this month. Find out who won a May listing...
1 May New to the PBS
New Top 25 Big Pharma is born
ICYMI: The buyout of Organon by Sun Pharma will create a new top-ranking pharma plus the other most popular stories this week
1 May Your Week in 5 Minutes
First May PBS listing goes to...
Cancer drug reimbursement win underlines the company's "ongoing investment in oncology" GM says, providing patients more choice
1 May
Rising cost of PBAC submissions
Department releases its proposed fee structure for the processes of listing on the PBS, and just how much it expects to raise
1 May
TGA eyes five new drug filings
Regulatory pathways handed out by the TGA signals five new drugs are on the cusp of being filed in the coming months, if not sooner
30 April
10-drug ANZ deal sealed
Exclusive commercial and licensing agreement could pave the way for 10 injectable, oral, and speciality drugs to be launched in ANZ
30 April
Next up: Ozempic pills for kids
Novo chases another first, aiming to file for a label expansion in the US and EU for oral semaglutide to treat T2 diabetes in kids and teens
30 April
New GM calls out PBS wait times
Miniscule decline in wait time between TGA approval and PBS listing is nowhere near good enough, new Country Leader warns
29 April
Pharma off target, doctors say
Industry's concerted efforts to meaningfully engage with Australian doctors seems to be missing the mark
29 April
Largest packaging plant opens
This 36,000 sqm greenfield facility provides a central hub for efficient distribution and supply chain management for pharmas
29 April
Lilly eyes next goldmine
After hitting the jackpot with its treatments for weight loss and diabetes, this company looks to crack another monster market
29 April
CSL falls to nine-year low
Another attack on vaccines by the US Administration hit the Aussie giant 'at the worst possible time' sending its share price tumbling
29 April
PBAC greenlights new drugs
Out of 26 new PBS listing submissions considered by the PBAC in March, a massive 23 were recommended
28 April
Big Pharma goes under the hammer
A new Top 25 pharma will be created under this AU$16B buyout deal with a global footprint extending to 150 countries
28 April
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.